侵蚀性皮囊性皮肤病和阿米万塔马布治疗肺癌:一个病例报告
Yseult Senterre1, Amandine Bouillenne1, Murielle Sabatiello2
1Department of Dermatology, CHU University Hospital, Liège, Belgium.
Case reports in dermatology
|July 10, 2025
概括
作为癌症治疗的一种药物阿米万塔马布 (amivantamab) 可以引起严重的皮肤反应,如侵蚀性性皮肤病 (EPD). 早期使用类固醇和抗生素治疗对于控制这种罕见但严重的副作用至关重要.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿米万塔马布是针对特定非小细胞肺癌的向治疗,作用于EGFR和MET受体.
- 由于其作用机制,皮肤不良事件与amivantamab是常见的.
- 这一案例突出了与这种治疗相关的罕见但严重的皮肤学并发症.
研究的目的:
- 报告用amivantamab治疗的患者发生严重侵蚀性性皮肤病 (EPD) 的情况.
- 强调识别和管理这种不良事件的重要性.
- 为了告知临床医生关于阿米万塔马布治疗的罕见但显著的副作用.
主要方法:
- 一个67岁的女性患有转移性腺素状瘤的病例介绍.
- 在一线化疗失败后使用amivantamab治疗.
- 尽管采取了预防措施,但严重侵蚀性性皮肤病的发展和管理的文件.
主要成果:
- 患者患有严重的侵蚀性性皮肤病,影响了头皮的50%以上.
- 这种情况需要剪发,以获得足够的局部护理.
- 患者需要一种治疗方案,包括口服类固醇,四环素和抗生素奶油.
结论:
- 侵蚀性状皮肤病是一种与amivantamab相关的异常和严重的不良事件.
- 及时识别和干预全身类固醇,四环素和局部抗生素是必不可少的.
- 临床医生的意识对于防止严重后果和复发至关重要.
相关概念视频
Pulmonary Tuberculosis V
243
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
243
Pulmonary Tuberculosis IV
207
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
Pulmonary Tuberculosis III
451
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
451
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Pulmonary Tuberculosis I
331
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
331
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K


